UnknownUnicorn14935167

CRSP, run up to earnings possible

Long
NASDAQ:CRSP   CRISPR Therapeutics AG
RR: 4.85
Target: 33.5%, 21d
Price has been downward since the share offering announcement. Run up to ER is possible.
Trade closed: stop reached
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.